Product Information

DILANTIN 50 MG INFATAB is a brand (anda) product labeled by Pfizer Inc., priced at $1.5737 per EA under NDC 00071000724. Its NADAC has been published 648 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Phenytoin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DILANTIN 50 MG INFATAB

Phenytoin
$1.5737per EA
High Outlier

Strength

50 mg/1

Manufacturer

Pfizer Inc.

NDC

00071000724

Classification

Brand (ANDA)

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

PHENYTOIN

Approval Type

Generic (ANDA)

FDA Application

ANDA084427

On Market Since

2/26/1979

Pharmacological Classes

Anti-epileptic Agent
Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C8 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 2D6 Inducers
Cytochrome P450 3A Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for DILANTIN 50 MG INFATAB has been published 648 times since Nov 28, 2013, and over the history we have for it it has risen 198.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5737 per EA
All-time high$1.5818 (May 13, 2026)
All-time low$0.5264 (Nov 28, 2013)
52-week high$1.5818
52-week low$1.5049
Median price$1.2210
Average price$1.1422
Largest weekly change+20.0% (Jan 6, 2016)
Weeks tracked648
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.3%

3M

-0.5%

6M

+4.5%

1Y

+4.0%

3Y

+9.5%

5Y

+22.9%

All

+198.9%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 88% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DILANTIN 50 MG INFATAB?

The current National Average Drug Acquisition Cost (NADAC) for DILANTIN 50 MG INFATAB, manufactured by Pfizer Inc., is $1.5737 per EA (NDC 00071000724), effective Jun 24, 2026.

How has the price of DILANTIN 50 MG INFATAB changed over time?

Over the history we have for it, the NADAC for DILANTIN 50 MG INFATAB has risen 198.9%. It has been tracked across 648 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DILANTIN 50 MG INFATAB?

Since Nov 28, 2013, the NADAC for DILANTIN 50 MG INFATAB has ranged from a low of $0.5264 (Nov 28, 2013) to a high of $1.5818 (May 13, 2026), with a median of $1.2210 per EA.

Are there cheaper alternatives to DILANTIN 50 MG INFATAB?

Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PHENYTOIN 50 MG TABLET CHEW, is $0.1841 per EA — about 88% below DILANTIN 50 MG INFATAB.

Who manufactures DILANTIN 50 MG INFATAB?

DILANTIN 50 MG INFATAB (NDC 00071000724) is labeled by Pfizer Inc., and CMS classifies it as a brand (anda) product.